These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27032769)

  • 1. Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis.
    Iskender B; Izgi K; Canatan H
    Mol Cell Biochem; 2016 May; 416(1-2):71-84. PubMed ID: 27032769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling.
    Iskender B; Izgi K; Hizar E; Jauch J; Arslanhan A; Yuksek EH; Canatan H
    Tumour Biol; 2016 Jun; 37(6):8281-91. PubMed ID: 26718217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?
    Iskender B; Izgi K; Sakalar C; Canatan H
    Tumour Biol; 2016 Feb; 37(2):1967-81. PubMed ID: 26334623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway.
    Feng LM; Wang XF; Huang QX
    J Biosci; 2017 Dec; 42(4):547-554. PubMed ID: 29229873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoquinone-induced reactive oxygen species causes apoptosis of chondrocytes via PI3K/Akt and p38kinase pathway.
    Yu SM; Kim SJ
    Exp Biol Med (Maywood); 2013 Jul; 238(7):811-20. PubMed ID: 23788172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells.
    Haiaty S; Rashidi MR; Akbarzadeh M; Bazmani A; Mostafazadeh M; Nikanfar S; Zibaei Z; Rahbarghazi R; Nouri M
    BMC Complement Med Ther; 2021 Mar; 21(1):83. PubMed ID: 33663486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-walled carbon nanotubes directly induce epithelial-mesenchymal transition in human bronchial epithelial cells via the TGF-β-mediated Akt/GSK-3β/SNAIL-1 signalling pathway.
    Polimeni M; Gulino GR; Gazzano E; Kopecka J; Marucco A; Fenoglio I; Cesano F; Campagnolo L; Magrini A; Pietroiusti A; Ghigo D; Aldieri E
    Part Fibre Toxicol; 2016 Jun; 13(1):27. PubMed ID: 27251132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
    Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
    Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1.
    Li J; Khan MA; Wei C; Cheng J; Chen H; Yang L; Ijaz I; Fu J
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29207526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.
    Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
    J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
    Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
    J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
    Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/β-catenin signaling pathway.
    Zhang M; Du H; Wang L; Yue Y; Zhang P; Huang Z; Lv W; Ma J; Shao Q; Ma M; Liang X; Yang T; Wang W; Zeng J; Chen G; Wang X; Fan J
    Chem Biol Interact; 2020 Apr; 320():109022. PubMed ID: 32112862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.
    Cursons J; Leuchowius KJ; Waltham M; Tomaskovic-Crook E; Foroutan M; Bracken CP; Redfern A; Crampin EJ; Street I; Davis MJ; Thompson EW
    Cell Commun Signal; 2015 May; 13():26. PubMed ID: 25975820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation.
    Byeon HK; Na HJ; Yang YJ; Ko S; Yoon SO; Ku M; Yang J; Kim JW; Ban MJ; Kim JH; Kim DH; Kim JM; Choi EC; Kim CH; Yoon JH; Koh YW
    Oncotarget; 2017 Jan; 8(1):596-609. PubMed ID: 27880942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of PEG-coated gold nanoparticles sensitize solid tumors to cold plasma by blocking the PI3K/AKT-driven signaling axis to suppress cellular transformation by inhibiting growth and EMT.
    Kaushik NK; Kaushik N; Yoo KC; Uddin N; Kim JS; Lee SJ; Choi EH
    Biomaterials; 2016 May; 87():118-130. PubMed ID: 26921841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
    Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
    Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway.
    Wang F; Ruan XJ; Zhang HY
    Tumori; 2015; 101(2):238-45. PubMed ID: 25908029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.